IgG4 Related disease - a retrospective descriptive study highlighting Canadian experiences in diagnosis and management

BMC Gastroenterology

Volumn 13, Issue 1, 2013, Pages

  Patel, Harshna ^a,b   Khalili, Korosh ^c   Kyoung, Kim T ^c   Yazdi, Leyla ^c   Lee, Eric ^d   May, Gary ^d   Kortan, Paul ^d   Coltescu, Catalina ^a   Hirschfield, Gideon M ^e  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b SCARBOROUGH HOSPITAL   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Autoimmune pancreatitis; IgG4; Sclerosing cholangitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; IMMUNOGLOBULIN G4; PREDNISONE; RITUXIMAB;

ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE PANCREATITIS; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANADA; CHOLESTASIS; CLINICAL FEATURE; CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRITERION VARIABLE; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DISEASE CLASSIFICATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; JAPANESE; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; OBSTRUCTIVE JAUNDICE; PAIN; PRURITUS; RACE DIFFERENCE; RETROSPECTIVE STUDY; SCLEROSING CHOLANGITIS; SEX DIFFERENCE; STEATORRHEA; WEIGHT REDUCTION;

AUTOIMMUNE DISEASES; CANADA; CHOLANGITIS, SCLEROSING; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PANCREATITIS; RETROSPECTIVE STUDIES;

EID: 84889791404     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-168     Document Type: Article

References (18)

1. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009, 58:1680-1689. 10.1136/gut.2008.155853, 19240063.
2. Sugumar A. Diagnosis and management of autoimmune pancreatitis. Gastroenterol Clinics North Am 2012, 41:9-22.
3. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas 2011, 40:352-358. 10.1097/MPA.0b013e3182142fd2, 21412117.
4. Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009, 44:503-517. 10.1007/s00535-009-0054-6, 19377842.
5. Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, et al. Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Annals of Surg 2003, 237:853-858. discussion 858-9.
6. Ghazale A, Chari ST, Zhang L, et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715. 10.1053/j.gastro.2007.12.009, 18222442.
7. Sah RP, Chari ST, Pannala R, et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010, 139:140-148. 10.1053/j.gastro.2010.03.054, 20353791.
8. Kawa S, Okazaki K, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2010, 45:355-369. 10.1007/s00535-009-0197-5, 20127119.
9. Okazaki K, Kawa S, Kamisawa T, et al. Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010, 45:249-265. 10.1007/s00535-009-0184-x, 20084528.
10. Kamisawa T, Shimosegawa T, Okazaki K, et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58:1504-1507. 10.1136/gut.2008.172908, 19398440.
11. Sandanayake NS, Church NI, Chapman MH, et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol: Off Clin Prac J Am Gastroenterol Assoc 2009, 7:1089-1096.
12. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 2006, 101:2070-2075. 10.1111/j.1572-0241.2006.00772.x, 16879434.
13. Alswat K, Al-Harthy N, Mazrani W, et al. The spectrum of sclerosing cholangitis and the relevance of IgG4 elevations in routine practice. Am J Gastroenterol 2012, 107:56-63. 10.1038/ajg.2011.375, 22068666.
14. Okazaki K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 41:626-631. 10.1007/s00535-006-1868-0, 2780630, 16932998.
15. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol: WJG 2006, 12:2487-2496.
16. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?. Am J Surg Pathol 2004, 28:1193-1203. 10.1097/01.pas.0000136449.37936.6c, 15316319.
17. Topazian M, Witzig TE, Smyrk TC, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc 2008, 6:364-366.
18. Webster GJ, Pereira SP, Chapman RW. Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis-overlapping or separate diseases?. J Hepatol 2009, 51:398-402. 10.1016/j.jhep.2009.04.010, 19505739.